The Toxicity of Lead and Lead‐Free Perovskite Precursors and Nanocrystals to Human Cells and Aquatic Organisms
Advanced Science · 2025
DOI: 10.1002/advs.202415574 ↗Kurz gefasst
Fachartikel in der Zeitschrift Advanced Science, 2025. Verfasst von Immacolata Maietta und 6 weiteren Autor:innen. Beteiligte Einrichtung: CINBIO, Grupo Inmunología, Universidade de Vigo, Vigo, 36310, Spain. Hauptthemen laut MEDLINE: Oxides, Calcium Compounds, Titanium, Lead. Die Arbeit wurde bisher 76-mal zitiert (Crossref) und nennt 36 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Xunta de Galicia, Spanish Ministerio de Ciencia e Innovación.
Abstract (Originalsprache)
Halide perovskites have emerged at the forefront of semiconductor materials for photovoltaic and light‐emitting devices. However, long‐term stability and toxicity are the major barriers to their commercialization. In particular, the toxicity of lead (Pb) and its environmental impact have prompted the exploration of lead‐free alternatives like tin (Sn) and bismuth (Bi). Herein, a cytotoxicity study of Pb‐based perovskite (CsPbBr 3 and CsPbI 3 ) and a lead‐free Cs 2 AgBiBr 6 nanocrystals in lung and liver cell lines and in blood cells are reported, revealing that both Pb and Bi exhibit mitogenic effects and oxidative stress in liver cells, cytotoxicity in pulmonary cells and a dose‐dependent hemolytic effect, raising concerns about their potential pulmonary‐hepato‐hemotoxicity. The zebrafish embryo tests reveal SnBr 2 displays a notably safer environmental impact profile at elevated concentrations, while Pb and Bi exhibit dose‐dependent toxicity. This study provides compelling evidence that Sn compounds demonstrate a safer toxicity profile in both human cells and aquatic organisms under the studied conditions, supporting their potential as a more environmentally friendly alternative. In contrast, Bi compounds exhibit a toxicity profile similar to Pb perovskites, warranting caution in its use as a substitute. These findings guide future research and regulatory efforts in the safety and sustainability of perovskite nanocrystals.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- CINBIO, Grupo Inmunología, Universidade de Vigo, Vigo, 36310, Spain.
- Inflammatory and Infectious Diseases and Immune Disorders Group, Galicia Sur Health Research Institute (IIS Galicia Sur), SERGAS-UVIGO, Spain.
- CINBIO, Materials Chemistry and Physics Group, Universidade de Vigo, Campus universitario, Vigo, 36310, Spain.
- Department of Physical Chemistry, CINBIO, Campus Universitario As Lagoas-Marcosende, Universidade de Vigo, Vigo, 36310, Spain.
- Department of Zoology, Genetics and Physical Anthropology, Faculty of Veterinary Science, Universidade de Santiago de Compostela, Lugo, 27002, Spain.
- Preclinical Animal Models Group, Health Research Institute of Santiago de Compostela, (IDIS), Santiago de Compostela, Spain.
ORCID-Profile: Lakshminarayana Polavarapu
Förderung
- Xunta de Galicia
- Spanish Ministerio de Ciencia e Innovación
Zitieren
APA
Maietta, I., Otero-Martínez, C., Fernández, S., Sánchez, L., González-Fernández, Á., Polavarapu, L., & Simón-Vázquez, R. (2025). The Toxicity of Lead and Lead‐Free Perovskite Precursors and Nanocrystals to Human Cells and Aquatic Organisms. Advanced Science. https://doi.org/10.1002/advs.202415574
Vancouver
Maietta I, Otero-Martínez C, Fernández S, Sánchez L, González-Fernández Á, Polavarapu L, et al. The Toxicity of Lead and Lead‐Free Perovskite Precursors and Nanocrystals to Human Cells and Aquatic Organisms. Advanced Science. 2025. doi:10.1002/advs.202415574
BibTeX
@article{Maietta2025,
author = {Maietta, Immacolata and Otero-Martínez, Clara and Fernández, Sabela and Sánchez, Laura and González-Fernández, África and Polavarapu, Lakshminarayana and Simón-Vázquez, Rosana},
title = {The Toxicity of Lead and Lead‐Free Perovskite Precursors and Nanocrystals to Human Cells and Aquatic Organisms},
journal = {Advanced Science},
year = {2025},
doi = {10.1002/advs.202415574}
}
EUVIMED